US20030109896A1 - Tissue removal methods and apparatus - Google Patents

Tissue removal methods and apparatus Download PDF

Info

Publication number
US20030109896A1
US20030109896A1 US10/334,476 US33447602A US2003109896A1 US 20030109896 A1 US20030109896 A1 US 20030109896A1 US 33447602 A US33447602 A US 33447602A US 2003109896 A1 US2003109896 A1 US 2003109896A1
Authority
US
United States
Prior art keywords
tissue
device
step
radially
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/334,476
Inventor
William Dubrul
Richard Fulton
Robert Curtis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artemis Medical Inc
Original Assignee
Artemis Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US7419998P priority Critical
Priority to US9024398P priority
Priority to US9273498P priority
Priority to US10528498P priority
Priority to US11486399P priority
Priority to US11742199P priority
Priority to US13777599P priority
Priority to US09/336,360 priority patent/US6270464B1/en
Priority to US14689299P priority
Priority to US15439499P priority
Priority to US20054600P priority
Priority to US09/588,278 priority patent/US6530923B1/en
Application filed by Artemis Medical Inc filed Critical Artemis Medical Inc
Priority to US10/334,476 priority patent/US20030109896A1/en
Publication of US20030109896A1 publication Critical patent/US20030109896A1/en
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY AGREEMENT Assignors: ARTEMIS MEDICAL, INC.
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/0233Pointed or sharp biopsy instruments
    • A61B10/0266Pointed or sharp biopsy instruments means for severing sample
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/221Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421Cannulas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908Soft tissue, e.g. breast tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3962Markers, e.g. radio-opaque or breast lesions markers palpable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50Clinical applications
    • A61B6/502Clinical applications involving diagnosis of breast, i.e. mammography

Abstract

Target tissues are accessed and removed using various types of devices and methods.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • This application is a divisional patent application of Patent Application No. 09/588,278 filed Jun. 5, 2000 entitled TISSUE REMOVAL METHODS AND APPARATUS. [0001]
  • Patent application Ser. No. 09/588,278 claims the benefit of the following provisional patent applications: Provisional Application No. 60/137,775 filed Jun. 4, 1999 and entitled TISSUE REMOVAL APPARATUS AND METHOD FOR USE; Provisional Application No. 60/146,892 filed Aug. 2, 1999 entitled DISEASE PREVENTING SHEATH APPARATUS AND METHODS FOR USE; Provisional Application No. 60/200,546 filed Apr. 27, 2000 and entitled DIAGNOSTIC AND THERAPEUTIC APPARATUSES AND METHODS FOR USE; Provisional Application No. 60/154,394 filed Sep. 17, 1999 and entitled ONCOLOGICAL APPARATUS AND METHOD FOR USE. Patent application Ser. No. 09/588,278 is also a continuation-in-part of U.S. patent application Ser. No. 09/336,360 filed Jun. 18, 1999 entitled BIOPSY LOCALIZATION METHOD AND DEVICE, which application claims priority from the following provisional applications: [0002]
  • Application No. 60/090,243, filed Jun. 22, 1998; [0003]
  • Application No. 60/092,734, filed Jul. 14, 1998; [0004]
  • Application No. 60/114,863, filed Jan. 6, 1999; and [0005]
  • Application No. 60/117,421, filed Jan. 25, 1999. [0006]
  • Patent application Ser. No. 09/588,278 is also a continuation-in-part of U.S. patent application Ser. No. 09/248,088 filed Feb. 9, 1999, which application claims benefit of the following provisional applications: [0007]
  • Application No. 60/074,199 filed Feb. 10, 1998; and [0008]
  • Application No. 60/105,284 filed Oct. 22, 1998.[0009]
  • BACKGROUND OF THE INVENTION
  • The M.D. Anderson Cancer Center in Houston, Tex. predicts that cancer will become the leading cause of death in the United States by the year 2002. Cancer presently results in over one thousand five hundred deaths every day in the United States (550,000 deaths every year). Therapy modalities for cancer are plentiful and continued to be researched with vigor. Still, the preferred treatment continues to be physical removal of the cancer. When applicable, surgical removal is preferred (breast, colon, brain, lung, kidney, etc.). Open, excisional, surgical removal is often extremely invasive so that efforts to remove cancerous tissue in less invasive ways continue, but have not yet been perfected. [0010]
  • The only cure for cancer continues to be the early diagnosis and subsequent early treatment. As cancer therapies continue at earlier stages of diagnosis, the cancerous tissue being operated on is also smaller. Early removal of the smaller cancers demand new techniques for removal and obliteration of these less invasive cancers. [0011]
  • There are a variety of techniques that attempt to accomplish less invasive cancer therapy, but so far without sufficiently improved results. For example, the ABBI system from U.S. Surgical Corporation and the Site Select system from Imagine Corporation, attempt to accomplish less invasive cancer therapy. However, conventional techniques require more than Minimally Invasive Surgery (MIS) techniques in that they require a large core (that is more than about 15 mm diameter) incision. Additionally, the Mammotome system from Johnson and Johnson and MIBB system from U.S. Surgical Corporation also require large core (over about 4 mm diameter) access to accomplish biopsy. [0012]
  • A recent convention held by the American Society of Surgical Oncologists on Mar. 13, 2000 reported that conventional stereotactic core biopsy (SCB) procedures fall short in providing definitive answers to detail precise surgical regimens after this SCB type vacuum assisted biopsy, especially with ductile carcinoma in situ (DCIS). Apparently these percutaneous systems damage “normal” tissue cells so that it is difficult to determine if the cells are “normal damaged” cells or early pre-cancerous (e.g. Atypical Ductal Hyerplasi (ADH)) cells. [0013]
  • A study presented by Dr. Ollila et al. from the University of North Carolina, Chapel Hill, demonstrated that histology and pathology is compromised using these conventional techniques because of the damage done to the removed tissue specimens. Hence, for many reasons, including the fact that DCIS is becoming more detectable and hence more prevalent in breast cancer diagnosis in the U.S., there is a growing need to improve upon conventional vacuum assisted core biopsy systems. [0014]
  • SUMMARY OF THE INVENTION
  • Broadly, the present invention is directed to procedures, including biopsy and tumorectomy methods, and associated apparatus which provide for less invasive techniques while also providing for enhanced tissue specimens being retrieved. [0015]
  • A first aspect of the invention is directed to a tissue removal method in which a tissue separation device is positioned at a target site within a patient. A tissue sample is separated by the movement of tissue separation element through the tissue at the target site. A factor relating to the restriction of the passage of the tissue separation element through the tissue is monitored so that energy supplied to the tissue separation element can be adjusted. The procedure may be carried out percutaneously. The method may include radially expanding one or more heated, wire-type tissue separation elements and then rotating the support shaft. The factor being monitored may include, for example, strain on the tissue separation element, the rotational force supplied to the device, the pressure exerted against the tissue by the tissue separation element, etc. Monitoring may also be done manually with tactile feedback to the user. [0016]
  • A related aspect of the invention is directed to a tissue removal assembly in which an elongate tissue separation device comprises a tissue separation element mounted to a support. The tissue separation element is movable from a retracted state to an extended state. A tissue separation element driver is operably coupled to the tissue separation element to permit the tissue separation element to separate a target tissue mass from a patient. The tissue separation element driver comprises an energy source coupled to the tissue separation device. A sensor is operably coupled to at least one of the tissue separation device and the tissue separation element driver and senses resistance to the separation of the target tissue mass from the patient. A feedback device operably couples the sensor and the tissue separation element driver so that the amount of energy supplied can be adjusted based on the resistance to the passage of the tissue separation element through the patient's tissue. [0017]
  • Certain advantages accrue through the use of the above-described tissue removal method and assembly. An appropriate amount of energy can be supplied to the tissue separation element so that when, for example, the tissue separation element is a wire which extends radially outwardly to form an arch passing through the target tissue, the wire can be heated so to cauterize the tissue it passes through as it moves from the radically retracted state to the radically extended state; this helps to prevent spreading of viable cancer tissue into non-cancerous tissue regions. Heating or otherwise energizing the tissue separation element with RF energy, vibrational or other mechanical energy, etc., may also reduce the force required to move the tissue separation element through tissue mass, especially when passing through dense or fibrotic tissue or a variation in densities. Once the tissue separation element has been fully extended, it may or may not need to be heated or otherwise energized to pass through non-diseased tissue surrounding the suspect tissue mass. Therefore, undesirable damage to healthy tissue may be minimized and the spread of cancerous tissue to non-cancerous tissue may be effectively eliminated. [0018]
  • A further aspect of the invention is directed to a method for helping to prevent seeding of a tissue track including positioning a protective device along the tissue track and then moving tissue from the target site, through an opening in the protective device and into an inner region of the protective device. The tissue is then moved along the tissue track and out of the patient while keeping the tissue within the device. The protective device may be maintained substantially in place along the tissue track as the tissue is moved out of the patient. [0019]
  • Another aspect of the invention is directed to percutaneous tissue mass retrieval assembly comprising a shaft, a radially expandable blocking element at the distal end of the shaft, a suspect tissue mass enveloping device movable from an enlarged, tissue mass-surrounding state to a contracted, tissue mass-constricting state so to enable the tissue mass to be removed from a target site with a reduced lateral size. [0020]
  • A still further aspect of the invention is directed to a method for maintaining access to a void within a patient by placing an access sleeve along a tissue track connecting an access site in the patient's skin and a void in the patient. This method may take place, for example, following the removal of a biopsy specimen, the removal creating the void. The method may also take place following removal of an entire suspect tissue mass as well. This method ensures convenient and accurate re-access to the void when, for example, an additional tissue sample is needed, therapeutic drugs are to be delivered to the void, a prosthesis is to be implanted, etc. [0021]
  • An additional aspect of the invention is directed to a method for removal of target material from a target site and includes percutaneously placing an expandable blocking element at a first position distal of the target material, expanding the expandable blocking element, percutaneously placing a removing element at a second position, at least substantially surrounding the target material with the blocking element and the removing element, and then removing the blocking element, the removing element and the target material therewith from the patient along a tissue track connecting the target site with an access site in the patient's skin. The expandable blocking element may be a radially expandable, tubular mesh material. The removing element may include a tubular mesh element having a radially expandable, open distal end. One or both of the removing element and blocking element may be at least partially radially collapsed prior to removing the blocking element, removing element and target material therewith from the patient. This method helps to ensure target material is properly captured and permits it to be removed percutaneously; the removal may be preceded by radially collapsing the blocking and/or removing elements to help reduce the size of the device passing through the access site in the patient's skin. [0022]
  • A still further aspect of the invention relates to a target material removing device including a shaft, first and second axially spaced-apart, radially expandable elements carried by a distal portion of the shaft. The expandable elements are remotely selectively movable between radially retracted and radially expanded states so that the expandable elements can be used to bracket target material to permit the target material to be removed from the patient along with the device. This device permits a surgeon to easily and accurately locate the target material, which is often very difficult to visually differentiate from surrounding tissue, by locating the expandable elements. The radially expandable elements are preferably sufficiently hard so as to be detectable by palpation. [0023]
  • A still another aspect to the invention is directed to a method for locating a target mass within a patient comprising extending the distal end of a shaft to a position distal of a target mass, positioning first and second radially expanding bracketing elements at positions distal of and proximal of the target mass, moving the bracketing elements from radially retracted states to radially expanded states thereby bracketing the target mass, and locating a target mass using the bracketing elements. The bracketing elements, when radially expanded, may define a bracketed region therebetween sized to completely contain the target mass. The target mass may be located by palpation of the bracketing elements or with the aid of a surgical incision at least partially exposing at least one of the bracketing elements. [0024]
  • An additional aspect to the invention is directed to a method for maintaining percutaneous access to an excisional site comprising positioning first and second locational elements within a patient at a target site, the locational elements carried by elongate elements extending from the locational elements along a tissue track and out through an access site in the patient's skin. The first elongate element and first locational element therewith are then removed from the patient and the target site is accessed using the second elongate element and second locational element therewith. The second or both the first and second locational elements may be radially expandable locational elements. This aspect of the invention provides the surgeon the ability to accurately locate the target site. It also permits one of the locational elements to be removed and one to be left at the target site. [0025]
  • A still additional aspect of the invention is directed to a percutaneous access assembly including first and second separately movable locational devices, each device including a shaft and a radially expandable element mounted to the shaft. The radially expandable elements are locatable adjacent to one another. [0026]
  • Other features and advantages of the invention will appear from the following description in which the preferred embodiments and methods have been set forth in detail in conjunction with the accompanying drawings.[0027]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. [0028] 1A-1C illustrate the use of a tissue removal assembly made according to the invention;
  • FIG. 2 shows the use of a sleeve which helps prevent seeding of a tissue track and provides access to a void within the patient; [0029]
  • FIGS. [0030] 3A-3H illustrate a further aspect of the invention by which percutaneous removal of target tissue from a target site within the patient is accomplished using a radially expandable/collapsible tubular shaft;
  • FIGS. [0031] 4A-4D show a method for percutaneously removing an entire tissue mass from a target site;
  • FIGS. [0032] 5A-5D illustrate a target tissue removing device including a pair of tissue engaging devices which bracket the target tissue; and
  • FIGS. [0033] 6A-6C show the use of a pair of locational elements, one of which is left in place after target tissue is removed to provide guidance for re-access to the target site.
  • DESCRIPTION OF THE SPECIFIC EMBODIMENTS
  • FIGS. [0034] 1A-1C illustrate the use of a tissue removal assembly 2. Tissue removal assembly 2 includes a support shaft 4 passing through an introducer sheath 5 extending from a handle 6. The distal portion 8 of shaft 4 has a pair of tissue separation wires 10 mounted thereto. Wires 10 are movable from a retracted state of FIG. 1A to a fully extended state of FIG. 1C by moving a slide 12 mounted to handle 6 as indicated in FIGS. 1A-1C. Wires 10 are typically made of tungsten or stainless steel and may have a round, rectangular or other cross-sectional shape depending upon the type of tissue and other matter expected to be encountered. U.S. patent application Ser. No. 09/248,088 and Provisional Applications 60/154,394 (filed Sep. 17, 1999 and entitled Oncological Apparatus and Method for Use) and 60/200,546 describe various tissue separation elements. Wires 10 are coupled to an energy source 14 to supply wires 10 with appropriate energy to aid the cutting or other separating actions of the wires, including electrical, RF, vibrational, electromagnetic, etc. Together, handle 6 and energy source 14 constitute a wire tissue separation element driver 16 because both act to help move wires 10 through tissue 18 beneath a skin surface 20 of the patient.
  • Appropriate sensors [0035] 22 are mounted to one or more of wires 10 and shaft 4. Sensors 22 may include strain gauge sensors, pressure sensors, temperature sensors, etc. Sensors 22 are coupled to a feedback device 24 through sheath 5; feedback device 24 is connected to energy source 14 to ensure that energy source 14 provides an appropriate level of energy to wires 10.
  • Assembly [0036] 2 is used to percutaneously access a target site 26 through an access site 28 in skin surface 20 while in the retraced state. The tip 30 of shaft 4 is positioned distally of the target tissue mass 32. In some situations it may be desirable to pass tip 30 directly through target tissue mass 32 while in other situations it may be desirable to have shaft 4 pass to one side of target tissue mass 32. Once properly positioned, which is preferably accomplished with the aid of remote visualization techniques, such as x-rays, ultrasound, etc., slide 12 is moved in a distal direction causing wires 10 to arc outwardly from the retracted state of FIG. 1A, through the intermediate extended state of FIG. 1B and to the fully extended state of FIG. 1C. Wires 10 are preferably energized, typically by heating using resistance or RF heating techniques, as wires 10 pass through tissue 18. This is very important when wires 10 pass through target tissue mass 32 and the target tissue mass contains, or possibly contains, cancerous or other diseased tissue. By appropriately energizing wires 10, the tissue wires 10 pass through is, for example, cauterized so that no viable diseased tissue is pulled along with the radially outwardly expanding wires; this helps to keep the healthy tissue surrounding target tissue mass 32 free from viable diseased tissue. In addition to heating the tissue, tissue removal assembly 2 may be provided with vibrational, reciprocating or other mechanical energy to help passage of wires 10 through tissue 18.
  • Once fully expanded, tissue removal assembly [0037] 2 is rotated, typically by the user manually grasping and rotating handle 6. If the desired, a motorized or other non-manual rotation of assembly 2 could be provided for. Sensors 22 provide appropriate information to feedback device 24 so to ensure a proper amount of energy is supplied to wires 10 to, among other things, ensure proper cauterization of the tissue as wires 10 are moved readily outwardly while not overly damaging the tissue. Once in the fully extended state of FIG. 1C, the amount of energy supplied to wires 10 may not need to be as great as when, for example, wires 10 pass through only healthy tissue. Therefore, if wires 10 cease to be driven and thus stop moving through the tissue, feedback can result in a halt in the supply of energy to wires 10.
  • In the embodiment of FIGS. [0038] 1A-1C two wires 10 are used. This causes target tissue mass 32 to be cut away from the surrounding tissue in two contiguous tissue masses. If desired, only a single wire 10 or more than two wires 10 could be used. Using the method described with respect to FIGS. 1A-1C, the entire target tissue mass 32 may be removed in a simultaneous manner. This aspect of the invention will be described in more detail below with reference to FIGS. 4A-4D. All or part of the procedure, such as expanding, cutting, rotating, energizing, etc., could be automated.
  • Additional aspects of the invention will be described below with reference to additional figures, with like structure referred to with like reference numerals. [0039]
  • FIG. 2 illustrates two additional aspects of the invention. A sleeve [0040] 36 is used to help prevent seeding of a tissue track 38 extending between access site 28 and target site 26. Protective sleeve 36 is positioned along tissue track 38 and has a distal opening 40, preferably positioned adjacent to or within target site 26, and an open interior 42. Target tissue 44 is moved from target site 26 through opening 40 and into open interior 42. FIG. 2 illustrates this having been accomplished using a tissue engagement device 45 having a radially expandable mesh device 46 at the distal end of a shaft 48. Mesh device 46 is of a type which can be movable from a generally cylindrical orientation, not shown, to the radially extended configuration shown in FIG. 2 by pushing the distal ends of the cylindrical mesh material towards one another. Examples of this type of mesh structure can be found in U.S. patent application Ser. No. 09/376,678 filed Aug. 18, 1999, entitled Target Tissue Localization Device and Method and in Provisional Application 60/200,546. Other methods and devices for moving target tissue 44 from target site 26 into interior 42 can also be used. Target tissue 44 can then be removed from the patient by either leaving protective sleeve 36 in place and sliding the target tissue out through the opened proximal end 50 of sleeve 36 or by removing the entire structure, that is protective sleeve 36, mesh device 46, shaft 48 and target tissue 44 therewith, from tissue track 38 of the patient.
  • A further aspect of the invention can also be discussed with reference to FIG. 2. In this aspect of the invention, access to a void [0041] 52 within a patient can be maintained by placing sleeve 36 along tissue track 38 and leaving it in place. This method may be accomplished after removal of, for example, a biopsy specimen or an entire suspect tissue mass. This provides convenient and accurate re-access to void 52. Such re-access may be used, for example, when additional tissue samples are needed, therapeutic drugs need to be delivered to void 52, a prosthesis is to be implanted into void 52, or for other reasons.
  • FIGS. [0042] 3A-3H illustrate another aspect of the invention by which percutaneous removal of target tissue 44 from target site 26 is accomplished. A hollow, radially expandable/collapsible tubular shaft 54 is passed along tissue track 38 when in a radially collapsed condition as shown in FIG. 3A. FIG. 3B illustrates the introduction of a tubular enlarger 56 including a conical tip 58 mounted to the distal end of a shaft 60 and a stabilizing sleeve 62 extending proximally from conical tip 58. As illustrated in FIGS. 3B and 3C, pushing enlarger 56 through shaft 54 causes the shaft to radially enlarge along its length; stabilizing sleeve 62 resists the tendency of shaft 54 to radially collapse. Once sleeve 62 is properly positioned within shaft 54, shaft 60 and tip 58 therewith are removed from within sleeve 62 as shown in FIG. 3D. Also, FIG. 3D illustrates the positioning of a tissue engagement device 45 to help draw a sample of target tissue 44 into the interior 64 of sleeve 62 as suggested in FIGS. 3D and 3E.
  • At this point a sample of the target tissue [0043] 44 may be removed from the patient by simultaneously removing shaft 54 in its enlarge diameter form, sleeve 62 and device 45 as a unit. Alternatively, stabilizing sleeve 62 may be removed as device 45 pulls tissue 44 into shaft 54 while shaft 54 remains in place. This suggested in FIGS. 3E and 3F and permits shaft 54 to return towards its initial, radially contracted condition thus causing the tissue sample housed therein to be radially compressed. The collected target tissue 44 remains within shaft 54 when sleeve 62 is removed from shaft 54 and mesh device 46 is collapsed (see FIG. 3F). Shaft 54 then naturally assumes a smaller diameter condition as shown in FIGS. 3F and 3G which permits shaft 54 and the target tissue therein to be removed through access site 28 as shown in FIGS. 3G and 3H. In this way the size of access site 28 may be smaller than the original size of target tissue 44. Device 45 may remain within shaft 54 during this removal from the patient, or device 45 may, as suggested in FIGS. 3G and 3H, be removed from shaft 54 along with sleeve 62.
  • The entire shaft [0044] 54 was enlarged in the embodiment of FIGS. 3A-3H. If desired, only the part of shaft 54 within the patient may need to be expanded. This would reduce the maximum size which access site 28 is forced to assume, even if only temporarily. The following U.S. Patents show radially-expanding dilators: U.S. Pat. Nos. 5,183,464; 5,431,676; 5,454,790.
  • FIGS. [0045] 4A-4D illustrate a method for percutaneously removing an entire tissue mass containing target tissue 44. A tissue removal assembly 66 includes a sheath 68 extending from a proximal end adapter 70 and passes through an access site 28 and along tissue track 38. Sheath 68 houses a tissue engagement device 45, shown in FIG. 4A, after having passed by or through target tissue 44 and manipulated to cause mesh device 46 to assume a radially expanded condition. Next, a tubular mesh device 72 is used to surround target tissue 44. Device 72 is of the type in which a tubular mesh material having an open distal end expands radially outwardly as it is compressed axially. That is, the resistance to the axial movement mesh device 72 causes it to contract axially and expand radially to assume the generally funnel-shaped configuration of FIG. 4B. As shown in FIG. 4B, mesh device 46 acts as a blocking element and mesh device 72 acts as a removing element. Together devices 46, 72 at least substantially surround, and preferably fully surround or envelope, target tissue 44.
  • The entire suspect tissue mass, that is the mass including target tissue [0046] 44 and an amount of surrounding tissue, can be removed through access site 28. To help prevent trauma to access site 28 during such removal, mesh device 46 and tubular mesh device 72 are caused to contract radially, thus compressing target tissue 44 into a smaller diameter mass for ease of removal from the patient. This is suggested in FIGS. 4C and 4D. The construction and use of structure similar to device 72 is described in patent application Ser. No. 09/248,008 and Provisional Application No. 60/200,546. Note that the structure shown in FIGS. 1A-1C could be used to severe target tissue 44 so that the entire suspect tissue mass, that is including target tissue 44, may be simultaneously removed as two contiguous pieces from the patient along the tissue track. It is expected that the entire suspect tissue mass could be severed into at most four contiguous pieces and still be simultaneously removed in a useful condition for further testing and/or evaluation. One such structure could use the cutting device of FIGS. 1A-1C plus a mesh material similar to tubular mesh device 72 which could be guided by expanded wires 10 to surround the suspect tissue mass. As seen by comparing FIGS. 4B and 4C, the largest lateral dimension of the access opening 28 is smaller than the largest lateral dimension of a suspect tissue mass prior to removal; radially or laterally squeezing the suspect tissue mass permits removal of the tissue mass with minimal trauma to the patient. The suspect tissue mass may be monitored for disease prior to, during and/or after removal from the patient.
  • FIGS. [0047] 5A-5D illustrate a target material removing device 78 including a sheath 80 within which a pair of tissue engaging devices 45 slidable pass. FIG. 5A illustrates device 78 passing through access site 28, along tissue track 38 and to target tissue 44 at target site 26. The first and second mesh devices 46A, 46B are placed at distal and proximal locations relative to target tissue 44. Once in position, mesh devices 46 are expanded as shown in FIGS. 5B and 5C so to bracket target tissue 44. Mesh devices 46A, 46B in their expanded conditions are sized so to define a bracketed region 82 therebetween. Bracketed region 82 is preferably sized to completely contain the tissue mass including target tissue 44. When so bracketed, the health professional can locate target tissue 44 by virtue of the expanded mesh devices 46. In one embodiment mesh devices 46A, 46B are harder than the surrounding tissue so that target tissue 44 within bracketed region 82 may be found by palpation. In addition, expanded meshed devices 46A, 46B guide a surgeon in locating and excising the entire target mass using surgical techniques. The using of bracketing guides 46A, 46B is important because target tissue 44 is often difficult to differentiate from surrounding tissue both in appearance and in feel. After the surgeon has accessed target tissue 44, guided by bracketing mesh devices 46, the entire suspect tissue mass 84 can be removed as a single mass as suggested in FIG. 5D. It is expected that the device of FIGS. 5A-5D may be useful in both percutaneous and open incisional situations.
  • FIG. 6A-[0048] 6C show the use of essentially the same type of structure as in FIGS. 5A-5D but for a different purpose. In this case devices 45 are used as locational elements. In the preferred embodiment both of the locational elements have radially expandable elements, such as mesh devices 46, both of which are positioned distally of target tissue 44. After removal of target tissue 44, which may occur along with proximal device 45B, device 45A remains in place adjacent to the excisional site or void 52 created by the removal of target tissue 44. This may be used to help maintain void 52 open to aid re-access to the site. Maintaining void 52 open also permits insertion of a space-saving device or structure into void 52. Instead of using two radially expandable elements as portions of the locational devices, locational device 45A could be simply, for example, a catheter shaft in which with the distal end would remain at the distal end of excisional site 52.
  • Modification and variation can be made to the disclosed embodiments without departing from the subject of the invention as defined in the following claims. For example, collapsing mesh device [0049] 46 could be replaced by, for example, an expandable balloon or an expandable malecot.
  • Any and all patents, patents applications and printed publications referred to above are hereby incorporated by reference. [0050]

Claims (45)

What is claimed is:
1. A breast tissue removal method comprising:
positioning a tissue separation device at a target site within a patient's breast the tissue separation device comprising a selectively energized tissue separation element;
separating a breast tissue sample by the movement of the tissue separation element through the tissue at the target site;
monitoring a factor relating to the restriction to the passage of the tissue separation element through the tissue during the separating step; and
adjusting, as needed, energy supplied to the tissue separation element based on the results of the monitoring step.
2. The method according to claim 1 wherein the positioning step is carried out percutaneously.
3. The method according to claim 1 wherein the separating step is carried out by radially expanding a wire-type tissue separation element from a support shaft and then rotating the support shaft about the support shaft axis.
4. The method according to claim 1 wherein the monitoring step monitors at least one of the following factors: strain, pressure, force, resistance.
5. The method according to claim 1 wherein the adjusting step adjusts at least one of the following types of energy: electrical, RF, mechanical, electromagnetic.
6. The method according to claim 1 wherein the monitoring step comprises manually monitoring said factor using tactile feedback to the user.
7. A breast tissue removal assembly comprising:
an elongate tissue separation device comprising a tissue separation element mounted to a support;
the tissue separation element movable from a retracted state to an extended state;
a tissue separation element driver operably coupled to the tissue separation element to permit the tissue separation element separate a target tissue mass from a patient, the tissue separation element driver comprising an energy source coupled to the tissue separation device;
a sensor, operably coupled to at least one of the tissue separation device and the tissue separation element driver, which senses the physical resistance to the separation of the target tissue mass from the patient's breast; and
a feedback device operably coupling the sensor and the tissue separation element driver so that the amount of energy supplied by the tissue separation element driver to the tissue separation element can be adjusted based on the physical restriction to the passage of the tissue separation element through the patient's breast.
8. The assembly according to claim 7 wherein the tissue separation element comprises a wire and the energy source comprises at least one of the following energy sources supplying energy to the wire: electrical, RF, vibrational.
9. The assembly according to claim 7 wherein the tissue separation driver further comprises a user-graspable handle at a proximal end of the support.
10. The assembly according to claim 7 wherein the support comprises an elongate support shaft having proximal and distal ends, the tissue separation element mounted to said distal end.
11. A method for the percutaneous removal of tissue from a target site within a continuous tissue mass of a patient comprising:
passing a hollow, radially expandable/collapsible portion of an elongate member along a tissue track within a continuous tissue mass of a patient, extending from an access site in a patient's skin to a target site in the patient, with the portion in a radially collapsed condition;
positioning the portion at a chosen position relative to the target site;
placing the portion in compression thereby radially expanding at least a part of the portion;
taking a tissue sample from the target site and housing said tissue sample within the portion;
removing the tissue sample from the patient while maintaining the tissue sample within the elongate member;
placing the portion in tension the thereby at least partially collapsing the part of the portion; and
removing the at least partially collapsed portion from the patient.
12. The method according to claim 11 wherein the passing step is carried out using a collapsible tube.
13. The method according to claim 11 wherein the tissue sample removing step takes place simultaneously with the portion removing step.
14. The method according to claim 11 wherein the tissue sample removing step takes place prior to the portion removing step.
15. The method according to claim 11 wherein the tension placing step:
takes place with the tissue sample housed within the portion; and
acts to radially compress the tissue sample prior to the removing step.
16. A percutaneous tissue sample removal assembly comprising:
an elongate member, at least a distal portion thereof being a radially expandable/collapsible, said distal portion having an open interior and an open distal end;
a distal portion expanding/collapsing device comprising a tubular mesh device which radially contracts when placed in tension and radially expands when placed in compression; and
a tissue sample retrieval device operable to position a tissue sample through the open distal end and into the open interior.
17. The assembly according to claim 16 wherein the entire elongate member is radially expandable/collapsible.
18. A percutaneous tissue mass retrieval assembly comprising:
a shaft having a distal end;
a radially expandable blocking element at the distal end of the shaft;
a suspect tissue mass enveloping device located proximal of the blocking element;
said tissue mass enveloping device movable from an enlarged, tissue mass-surrounding state to a contracted, tissue mass-constricting state so to enable said tissue mass to be removed from a target site with a reduced lateral size.
19. The assembly according to claim 18 further comprising:
an introducer sheath, said shaft being movable within the sheath and the enveloping device extendable from the introducer sheath towards the blocking element.
20. The assembly according to claim 18 wherein the enveloping device comprises an open-ended, axially compressible/radially expandable tubular braided element.
21. A method for maintaining access to a void within a breast of a patient, comprising:
creating a tissue void within a breast of a patient by the removal of target material from a continuous tissue mass at a target site, and through a tissue track extending from the target site and out an access site in the patient's skin; and
placing an access sleeve along the tissue track, whereby access to the void is maintained.
22. The method according to claim 21 wherein the creating step comprises removal of a biopsy specimen.
23. The method according to claim 21 wherein the creating step comprises removal of an entire suspect tissue mass.
24. A device for removing target material from a patient comprising:
a shaft having a proximal portion, a distal portion and an axis; and
first and second axially spaced-apart, radially expandable elements carried by the distal portion of the shaft, the expandable elements being remotely selectively movable between radially retracted and radially expanded states;
the radially expandable elements being sufficiently hard and sufficiently large so to be detectable by palpation;
whereby said radially expandable elements can be used to bracket target material so the target material can be removed from a patient along with the device.
25. The device according to claim 24 wherein the radially expandable elements are generally disk-shaped when in the radially expanded state.
26. The device according to claim 24 wherein the shaft comprises first and second independently movable shafts passing through a sheath.
27. The device according to claim 24 configured for percutaneous use.
28. A method for percutaneously locating a target mass within a patient comprising:
extending the distal end of a shaft to a position distal of a target mass;
independently positioning first and second radially expanding bracketing elements at positions distal of and proximal of the target mass;
moving the bracketing elements from radially retracted states to radially expanded states thereby bracketing the target mass; and
locating the target mass using the bracketing elements.
29. A method according to claim 28 wherein the locating step is carried out by other than surgical incisional techniques.
30. The method according to claim 28 wherein the moving step is carried out so the bracketing elements define a bracketed region therebetween sized to completely contain the target mass.
31. The method according to claim 28 wherein the locating step is carried out by palpation of the bracketing elements.
32. A method for helping to prevent seeding of a tissue track with cells from the vicinity of a breast tissue target site, the tissue track defined within a continuous breast tissue mass and extending between an access site in a patient's skin and the target site, comprising:
positioning an elongate protective device along the tissue track within the continuous breast tissue mass, the device having a wall, an opening at a distal end thereof, and an open inner region;
locating the distal end of the protective device at a position adjacent to and proximal of the target site;
moving tissue from the target site, through the opening in the device and into the inner region; and
moving the tissue along the tissue track and out of the patient while keeping the tissue within the device, the wall preventing seeding of the tissue track by the tissue.
33. The method according to claim 32 wherein the positioning step is carried out using an open-ended tubular protective device.
34. The method according to claim 32 further comprising maintaining the protective device substantially in place axially along the tissue path during the second moving step.
35. The method according to claim 32 wherein the positioning step is carried out using a radially expandable and collapsible protective device.
36. The method according to claim 35 wherein:
the positioning step is carried out with the protective device in a radially-collapsed state; and further comprising:
expanding at least a distal portion of the protective device from the radially-collapsed state to a radially-expanded state prior to the tissue moving step.
37. The method according to claim 36 further comprising collapsing the protective device from the radially-expanded state to a second radially-collapsed state prior to the tissue moving step, whereby the size of the access site may be smaller than the tissue moved from the target site.
38. The method according to claim 37 wherein the expanding step is carried out using a tubular enlarger extendable into the protective device during said expanding step, the tubular expander being removable from the protective device during the collapsing step.
39. A method for maintaining percutaneous access to an excisional site comprising:
positioning first and second locational elements within a patient at a target site, the first and second locational elements carried by first and second elongate elements, the first and second elongate elements extending from the locational elements at the target site, along a tissue track and out through an access site in the patient's skin;
removing the first elongate element and first locational element therewith from the patient; and
accessing the target site using the second elongate element and second locational element therewith.
40. The method according to claim 39 wherein the positioning step is carried out with a radially expandable second locational element.
41. The method according to claim 40 further comprising radially expanding the second locational element from a collapsed condition to an expanded condition before the accessing step.
42. The method according to claim 41 wherein the expanding step is carried out with the second locational element comprising a mesh device.
43. The method according to claim 41 wherein the positioning step is carried out with radially expandable first and second location elements, and further comprising expanding the first location element from a collapsed condition to an expanded condition and then contracting the first location element from the expanded condition to a second collapsed condition.
44. The method according to claim 41 wherein the radial expansion of second element acts to maintain an open space at the target site.
45. A percutaneous access assembly comprising:
first and second separately movable locational devices, each said device comprising a shaft and a radially expandable element mounted to the shaft; and
said radially expandable elements locatable adjacent one another.
US10/334,476 1998-02-10 2002-12-31 Tissue removal methods and apparatus Abandoned US20030109896A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US7419998P true 1998-02-10 1998-02-10
US9024398P true 1998-06-22 1998-06-22
US9273498P true 1998-07-14 1998-07-14
US10528498P true 1998-10-22 1998-10-22
US11486399P true 1999-01-06 1999-01-06
US11742199P true 1999-01-27 1999-01-27
US13777599P true 1999-06-04 1999-06-04
US09/336,360 US6270464B1 (en) 1998-06-22 1999-06-18 Biopsy localization method and device
US14689299P true 1999-08-02 1999-08-02
US15439499P true 1999-09-17 1999-09-17
US20054600P true 2000-04-27 2000-04-27
US09/588,278 US6530923B1 (en) 1998-02-10 2000-06-05 Tissue removal methods and apparatus
US10/334,476 US20030109896A1 (en) 1998-02-10 2002-12-31 Tissue removal methods and apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/334,476 US20030109896A1 (en) 1998-02-10 2002-12-31 Tissue removal methods and apparatus

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/336,360 Division US6270464B1 (en) 1998-06-22 1999-06-18 Biopsy localization method and device
US09/588,278 Division US6530923B1 (en) 1998-02-10 2000-06-05 Tissue removal methods and apparatus

Publications (1)

Publication Number Publication Date
US20030109896A1 true US20030109896A1 (en) 2003-06-12

Family

ID=27583717

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/588,278 Active 2019-07-07 US6530923B1 (en) 1998-02-10 2000-06-05 Tissue removal methods and apparatus
US10/334,476 Abandoned US20030109896A1 (en) 1998-02-10 2002-12-31 Tissue removal methods and apparatus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/588,278 Active 2019-07-07 US6530923B1 (en) 1998-02-10 2000-06-05 Tissue removal methods and apparatus

Country Status (1)

Country Link
US (2) US6530923B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846175B2 (en) 2006-04-03 2010-12-07 Medrad, Inc. Guidewire and collapsable filter system
US9498604B2 (en) 1997-11-12 2016-11-22 Genesis Technologies Llc Medical device and method
US9561094B2 (en) 2010-07-23 2017-02-07 Nfinium Vascular Technologies, Llc Devices and methods for treating venous diseases
US10252036B2 (en) 2011-12-19 2019-04-09 Cook Medical Technologies Llc Thrombus removal apparatus and method

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4255208B2 (en) * 1997-07-24 2009-04-15 レックス メディカル リミテッド パートナーシップ Apparatus for ablating a subcutaneous target tissue mass was
US6626903B2 (en) * 1997-07-24 2003-09-30 Rex Medical, L.P. Surgical biopsy device
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
US20030204188A1 (en) 2001-11-07 2003-10-30 Artemis Medical, Inc. Tissue separating and localizing catheter assembly
US20030163147A1 (en) * 2002-02-22 2003-08-28 Rabiner Robert A. Apparatus and method for using a vascular introducer with an ultrasonic probe
US7828796B2 (en) * 2003-01-21 2010-11-09 Baylis Medical Company Inc. Method for creating a channel through an occlusion and apparatus therefor
US7534242B2 (en) 2003-02-25 2009-05-19 Artemis Medical, Inc. Tissue separating catheter assembly and method
US20050059993A1 (en) * 2003-09-17 2005-03-17 Kamal Ramzipoor Embolectomy device
US20050159772A1 (en) * 2004-01-20 2005-07-21 Scimed Life Systems, Inc. Sheath for use with an embolic protection filtering device
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
WO2005094283A2 (en) 2004-03-25 2005-10-13 Hauser David L Vascular filter device
US8366735B2 (en) * 2004-09-10 2013-02-05 Penumbra, Inc. System and method for treating ischemic stroke
US20060058837A1 (en) * 2004-09-10 2006-03-16 Arani Bose System and method for treating ischemic stroke
US9655633B2 (en) 2004-09-10 2017-05-23 Penumbra, Inc. System and method for treating ischemic stroke
US20060212062A1 (en) * 2005-03-16 2006-09-21 David Farascioni Radially expandable access system including trocar seal
US20060224178A1 (en) * 2005-04-05 2006-10-05 Boston Scientific Scimed, Inc. Expandable medical retrieval device and related methods of use
US20070185520A1 (en) * 2006-02-07 2007-08-09 Boston Scientific Scimed, Inc. Detachable medical immobilization device and related methods of use
US20100204672A1 (en) * 2009-02-12 2010-08-12 Penumra, Inc. System and method for treating ischemic stroke
US8430826B2 (en) 2009-03-04 2013-04-30 Covidien Lp Specimen retrieval apparatus
US8585712B2 (en) * 2010-02-03 2013-11-19 Covidien Lp Surgical retrieval apparatus
WO2017023674A1 (en) 2015-07-31 2017-02-09 Polygon Medical, Inc. Polypectomy systems, devices, and methods

Citations (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996938A (en) * 1975-07-10 1976-12-14 Clark Iii William T Expanding mesh catheter
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4608965A (en) * 1985-03-27 1986-09-02 Anspach Jr William E Endoscope retainer and tissue retracting device
US4611594A (en) * 1984-04-11 1986-09-16 Northwestern University Medical instrument for containment and removal of calculi
US4638802A (en) * 1984-09-21 1987-01-27 Olympus Optical Co., Ltd. High frequency instrument for incision and excision
US4650466A (en) * 1985-11-01 1987-03-17 Angiobrade Partners Angioplasty device
US4799495A (en) * 1987-03-20 1989-01-24 National Standard Company Localization needle assembly
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US5030201A (en) * 1989-11-24 1991-07-09 Aubrey Palestrant Expandable atherectomy catheter device
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5102415A (en) * 1989-09-06 1992-04-07 Guenther Rolf W Apparatus for removing blood clots from arteries and veins
US5183464A (en) * 1991-05-17 1993-02-02 Interventional Thermodynamics, Inc. Radially expandable dilator
US5183463A (en) * 1989-02-03 1993-02-02 Elie Debbas Apparatus for locating a breast mass
US5221269A (en) * 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US5330483A (en) * 1992-12-18 1994-07-19 Advanced Surgical Inc. Specimen reduction device
US5344420A (en) * 1991-02-13 1994-09-06 Applied Medical Resources Corporation Surgical trocar
US5370660A (en) * 1993-11-01 1994-12-06 Cordis Corporation Apparatus and method for delivering a vessel plug into the body of a patient
US5415656A (en) * 1993-09-28 1995-05-16 American Medical Systems, Inc. Electrosurgical apparatus
US5431676A (en) * 1993-03-05 1995-07-11 Innerdyne Medical, Inc. Trocar system having expandable port
US5454790A (en) * 1994-05-09 1995-10-03 Innerdyne, Inc. Method and apparatus for catheterization access
US5634883A (en) * 1991-05-29 1997-06-03 Origin Medsystems, Inc. Apparatus for peritoneal retraction
US5643282A (en) * 1994-08-22 1997-07-01 Kieturakis; Maciej J. Surgical instrument and method for removing tissue from an endoscopic workspace
US5653684A (en) * 1992-06-26 1997-08-05 Schneider (Usa), Inc. Catheter with expandable wire mesh tip
US5709697A (en) * 1995-11-22 1998-01-20 United States Surgical Corporation Apparatus and method for removing tissue
US5735289A (en) * 1996-08-08 1998-04-07 Pfeffer; Herbert G. Method and apparatus for organic specimen retrieval
US5792157A (en) * 1992-11-13 1998-08-11 Scimed Life Systems, Inc. Expandable intravascular occlusion material removal devices and methods of use
US5795308A (en) * 1995-03-09 1998-08-18 Russin; Lincoln D. Apparatus for coaxial breast biopsy
US5794626A (en) * 1994-08-18 1998-08-18 Kieturakis; Maciej J. Excisional stereotactic apparatus
US5803901A (en) * 1991-05-29 1998-09-08 Origin Medsystems, Inc. Inflatable devices for separating layers of tissue and methods of using
US5807276A (en) * 1995-03-09 1998-09-15 Russin; Lincoln David Biopsy device and method
US5827324A (en) * 1997-03-06 1998-10-27 Scimed Life Systems, Inc. Distal protection device
US5868708A (en) * 1997-05-07 1999-02-09 Applied Medical Resources Corporation Balloon catheter apparatus and method
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US6022362A (en) * 1998-09-03 2000-02-08 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6027520A (en) * 1997-05-08 2000-02-22 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US6036698A (en) * 1998-10-30 2000-03-14 Vivant Medical, Inc. Expandable ring percutaneous tissue removal device
US6038488A (en) * 1997-02-27 2000-03-14 Bertec Corporation Catheter simulation device
US6053876A (en) * 1999-06-09 2000-04-25 Fisher; John Apparatus and method for marking non-palpable lesions
US6113593A (en) * 1999-02-01 2000-09-05 Tu; Lily Chen Ablation apparatus having temperature and force sensing capabilities
US6136014A (en) * 1998-09-01 2000-10-24 Vivant Medical, Inc. Percutaneous tissue removal device
US6161034A (en) * 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6238412B1 (en) * 1997-11-12 2001-05-29 William Dubrul Biological passageway occlusion removal
US6261241B1 (en) * 1998-03-03 2001-07-17 Senorx, Inc. Electrosurgical biopsy device and method
US6277083B1 (en) * 1999-12-27 2001-08-21 Neothermia Corporation Minimally invasive intact recovery of tissue
US6312429B1 (en) * 1998-09-01 2001-11-06 Senorx, Inc. Electrosurgical lesion location device
US6331166B1 (en) * 1998-03-03 2001-12-18 Senorx, Inc. Breast biopsy system and method
US20020007130A1 (en) * 1998-03-03 2002-01-17 Senorx, Inc. Methods and apparatus for securing medical instruments to desired locations in a patients body
US6344026B1 (en) * 1998-04-08 2002-02-05 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US20020016555A1 (en) * 1994-03-24 2002-02-07 Ritchart Mark A. Methods and devices for automated biopsy and collection of soft tissue
US20020019640A1 (en) * 1997-07-24 2002-02-14 Rex Medical Breast surgery method and apparatus
US20020026201A1 (en) * 1994-09-16 2002-02-28 Foerster Seth A. Methods for defining and marking tissue
US6440147B1 (en) * 1998-09-03 2002-08-27 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6652516B1 (en) * 1995-08-15 2003-11-25 Rita Medical Systems, Inc. Cell necrosis apparatus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2821048C2 (en) 1978-05-13 1980-07-17 Willy Ruesch Gmbh & Co Kg, 7053 Kernen
DE3913935A1 (en) 1989-04-27 1990-10-31 Wiedeck Joerg Guenter Dr Med Catheter for removing stones from the ureter - consists of plastics tube with retractable mandrel
US5443515A (en) 1994-01-26 1995-08-22 Implex Corporation Vertebral body prosthetic implant with slidably positionable stabilizing member
US6086543A (en) 1998-06-24 2000-07-11 Rubicor Medical, Inc. Fine needle and core biopsy devices and methods
AU7703501A (en) 2000-07-18 2002-01-30 Senorx Inc Apparatus and method for tissue capture

Patent Citations (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996938A (en) * 1975-07-10 1976-12-14 Clark Iii William T Expanding mesh catheter
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4611594A (en) * 1984-04-11 1986-09-16 Northwestern University Medical instrument for containment and removal of calculi
US4638802A (en) * 1984-09-21 1987-01-27 Olympus Optical Co., Ltd. High frequency instrument for incision and excision
US4608965A (en) * 1985-03-27 1986-09-02 Anspach Jr William E Endoscope retainer and tissue retracting device
US4650466A (en) * 1985-11-01 1987-03-17 Angiobrade Partners Angioplasty device
US4799495A (en) * 1987-03-20 1989-01-24 National Standard Company Localization needle assembly
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US5183463A (en) * 1989-02-03 1993-02-02 Elie Debbas Apparatus for locating a breast mass
US5102415A (en) * 1989-09-06 1992-04-07 Guenther Rolf W Apparatus for removing blood clots from arteries and veins
US5030201A (en) * 1989-11-24 1991-07-09 Aubrey Palestrant Expandable atherectomy catheter device
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5221269A (en) * 1990-10-15 1993-06-22 Cook Incorporated Guide for localizing a nonpalpable breast lesion
US5344420A (en) * 1991-02-13 1994-09-06 Applied Medical Resources Corporation Surgical trocar
US5183464A (en) * 1991-05-17 1993-02-02 Interventional Thermodynamics, Inc. Radially expandable dilator
US5634883A (en) * 1991-05-29 1997-06-03 Origin Medsystems, Inc. Apparatus for peritoneal retraction
US5803901A (en) * 1991-05-29 1998-09-08 Origin Medsystems, Inc. Inflatable devices for separating layers of tissue and methods of using
US5653684A (en) * 1992-06-26 1997-08-05 Schneider (Usa), Inc. Catheter with expandable wire mesh tip
US5792157A (en) * 1992-11-13 1998-08-11 Scimed Life Systems, Inc. Expandable intravascular occlusion material removal devices and methods of use
US5330483A (en) * 1992-12-18 1994-07-19 Advanced Surgical Inc. Specimen reduction device
US5431676A (en) * 1993-03-05 1995-07-11 Innerdyne Medical, Inc. Trocar system having expandable port
US5415656A (en) * 1993-09-28 1995-05-16 American Medical Systems, Inc. Electrosurgical apparatus
US5370660A (en) * 1993-11-01 1994-12-06 Cordis Corporation Apparatus and method for delivering a vessel plug into the body of a patient
US20020016555A1 (en) * 1994-03-24 2002-02-07 Ritchart Mark A. Methods and devices for automated biopsy and collection of soft tissue
US5454790A (en) * 1994-05-09 1995-10-03 Innerdyne, Inc. Method and apparatus for catheterization access
US5794626A (en) * 1994-08-18 1998-08-18 Kieturakis; Maciej J. Excisional stereotactic apparatus
US5643282A (en) * 1994-08-22 1997-07-01 Kieturakis; Maciej J. Surgical instrument and method for removing tissue from an endoscopic workspace
US20020026201A1 (en) * 1994-09-16 2002-02-28 Foerster Seth A. Methods for defining and marking tissue
US5807276A (en) * 1995-03-09 1998-09-15 Russin; Lincoln David Biopsy device and method
US5795308A (en) * 1995-03-09 1998-08-18 Russin; Lincoln D. Apparatus for coaxial breast biopsy
US6652516B1 (en) * 1995-08-15 2003-11-25 Rita Medical Systems, Inc. Cell necrosis apparatus
US5709697A (en) * 1995-11-22 1998-01-20 United States Surgical Corporation Apparatus and method for removing tissue
US5735289A (en) * 1996-08-08 1998-04-07 Pfeffer; Herbert G. Method and apparatus for organic specimen retrieval
US6038488A (en) * 1997-02-27 2000-03-14 Bertec Corporation Catheter simulation device
US5827324A (en) * 1997-03-06 1998-10-27 Scimed Life Systems, Inc. Distal protection device
US5868708A (en) * 1997-05-07 1999-02-09 Applied Medical Resources Corporation Balloon catheter apparatus and method
US6027520A (en) * 1997-05-08 2000-02-22 Embol-X, Inc. Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US20020019640A1 (en) * 1997-07-24 2002-02-14 Rex Medical Breast surgery method and apparatus
US6238412B1 (en) * 1997-11-12 2001-05-29 William Dubrul Biological passageway occlusion removal
US20020007130A1 (en) * 1998-03-03 2002-01-17 Senorx, Inc. Methods and apparatus for securing medical instruments to desired locations in a patients body
US6261241B1 (en) * 1998-03-03 2001-07-17 Senorx, Inc. Electrosurgical biopsy device and method
US6331166B1 (en) * 1998-03-03 2001-12-18 Senorx, Inc. Breast biopsy system and method
US6344026B1 (en) * 1998-04-08 2002-02-05 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US6312429B1 (en) * 1998-09-01 2001-11-06 Senorx, Inc. Electrosurgical lesion location device
US6136014A (en) * 1998-09-01 2000-10-24 Vivant Medical, Inc. Percutaneous tissue removal device
US6440147B1 (en) * 1998-09-03 2002-08-27 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6022362A (en) * 1998-09-03 2000-02-08 Rubicor Medical, Inc. Excisional biopsy devices and methods
US6036698A (en) * 1998-10-30 2000-03-14 Vivant Medical, Inc. Expandable ring percutaneous tissue removal device
US6113593A (en) * 1999-02-01 2000-09-05 Tu; Lily Chen Ablation apparatus having temperature and force sensing capabilities
US6161034A (en) * 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US6053876A (en) * 1999-06-09 2000-04-25 Fisher; John Apparatus and method for marking non-palpable lesions
US6277083B1 (en) * 1999-12-27 2001-08-21 Neothermia Corporation Minimally invasive intact recovery of tissue

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498604B2 (en) 1997-11-12 2016-11-22 Genesis Technologies Llc Medical device and method
US7846175B2 (en) 2006-04-03 2010-12-07 Medrad, Inc. Guidewire and collapsable filter system
US9561094B2 (en) 2010-07-23 2017-02-07 Nfinium Vascular Technologies, Llc Devices and methods for treating venous diseases
US10252036B2 (en) 2011-12-19 2019-04-09 Cook Medical Technologies Llc Thrombus removal apparatus and method

Also Published As

Publication number Publication date
US6530923B1 (en) 2003-03-11

Similar Documents

Publication Publication Date Title
US5980469A (en) Method and apparatus for automated biopsy and collection of soft tissue
US6056700A (en) Biopsy marker assembly and method of use
US6261241B1 (en) Electrosurgical biopsy device and method
US8075569B2 (en) Biopsy devices and methods
US7419472B2 (en) Biopsy instrument with internal specimen collection mechanism
EP2298154B1 (en) Improved device for accurately marking tissue
US5848978A (en) Surgical biopsy device
US6238355B1 (en) Tumortherapy device and method
CA2341528C (en) Methods and apparatus for securing medical instruments to desired locations in a patient's body
EP1026992B1 (en) Biopsy apparatus
Liberman et al. Clip placement after stereotactic vacuum-assisted breast biopsy.
DE69733782T2 (en) Device for marking tissue
EP1545316B1 (en) Biopsy devices
EP0983749B1 (en) Excisional biopsy device
JP3920219B2 (en) Medical device with a tip having a flexible
DE60223270T2 (en) Devices for tissue separation and removal
JP4070907B2 (en) Implantable surgical marker
US9980707B2 (en) Endoscopic ultrasound-guided biopsy needle
US6840948B2 (en) Device for removal of tissue lesions
US6855140B2 (en) Method of tissue lesion removal
US6454727B1 (en) Tissue acquisition system and method of use
EP1424930B8 (en) Biopsy marker delivery system
JP2553685B2 (en) Site of the lesion puncture needle
JP3647863B2 (en) Pull-out apparatus of the large number biopsy specimen
CA2199864C (en) Methods and devices for defining and marking tissue

Legal Events

Date Code Title Description
AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text: SECURITY AGREEMENT;ASSIGNOR:ARTEMIS MEDICAL, INC.;REEL/FRAME:024672/0377

Effective date: 20100709